The Gap Fund for Early-Stage Development of New Healthcare Interventions provides funding to generate critical data that builds confidence in developing a new or repurposed medicine, medical device, diagnostic test, or other medical intervention.
The concept for the product should be backed by prior funding. Projects should focus on one high-risk step, not multiple, to ensure efficient management. This step must address the crucial missing evidence needed to rapidly de-risk onward development or determine failure.
The Gap Fund bridges the smaller Impact Acceleration Account (IAA) and the larger Developmental Pathway Funding Scheme (DPFS).
Deadline: 9 July 2025
For more information and how to apply, click here.
